Extracorporeal Adsorption Following Infusion of Radiolabeled Anti-CD20 Antibody Clears Unbound Radioimmunoconjugate from the Circulation and Reduces Radiation Exposure of Normal Organs in the Nonhuman Primate.
Damian J. Green(Sylvester Comprehensive Cancer Center), Oliver W. Press(Fred Hutch Cancer Center), Eneida R. Nemecek(Oregon Health & Science University), Don K. Hamlin(University of Washington), John M. Pagel(University of Washington), Yukang Lin(Fred Hutch Cancer Center), Anastasia Pantelias(Fred Hutch Cancer Center), Nathan Hedin(University of Washington), Darrell R. Fisher(Richland Community College), Rune Nilsson, Ajay K. Gopal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bengt Sandberg(Active Biotech (Sweden)), D. Scott Wilbur(University of Washington)
Cited by 1
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k